Delivery Order SPE2DB20D3103-SPE2DB25FM3D1

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Enoxaparin 80 mg/0.8 ml syringes. The contract has a ceiling value of $2,257.11 and is a firm fixed-price delivery order contract with a completion date of January 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of enoxaparin 120 mg/0.8 ml syringes. The $1,340.31 delivery order is a firm fixed-price contract with an ultimate completion date of August 10, 2022. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,659.98 firm fixed-price delivery order is for the supply of 4566556101 - ENOXAPARIN 120 MG/0.8 ML SYR 0.8ML, a specialty medication. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This is a $1,135.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 150 mg/mL enoxaparin syringes, with a period of performance through May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,478.35 firm fixed-price contract is for the delivery of 80 mg/0.8 mL syringes of the anticoagulant drug enoxaparin, with a completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Enoxaparin 80 mg/0.8 mL syringes, a critical care medication. The contract has a ceiling value of $1,032.12 and an ultimate completion date of September 11, 2024. This contract is not set aside for any specific business category. Amerisourcebergen holds several...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FQ1X6, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565713260 - ENOXAPARIN 40 MG/0.4 ML SYR 0.4ML, with a ceiling value of $3,603.84 and a completion date of September 9, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565007402 ENOXAPARIN 150 MG/ML SYRINGE. The contract, valued at $2,216.33, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract has no set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that provides a wide range of medical products and supplies to various federal agencies, including the Department of...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 80 mg/0.8 mL syringes of the pharmaceutical product enoxaparin. The $2,781.10 delivery order supports the provision of pharmaceuticals and medical supplies for military treatment programs and facilities. No set aside designation was used. AmerisourceBergen Drug Corp is an experienced federal contractor,...
Defense Logistics Agency awarded a $412 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for Enoxaparin 150 MG/ML syringes. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its place of performance in Conshohocken, Pennsylvania by September 28, 2023. The contract was awarded on September 27, 2023 and utilizes no set-aside designation. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM3D1
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.07, is for the delivery of 4,566,926,388 units of Enoxaparin 80 mg/0.8 ml syringes.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price pricing type and does not utilize any set-aside designation, indicating open competition.

The award is part of AmerisourceBergen's broader portfolio of federal contracts, which also includes an IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:34 AM